---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-033856"
form_type: "8-K"
ticker: "NKTR"
cik: "0000906709"
company_name: "NEKTAR THERAPEUTICS"
filed_at: "2024-04-17T23:59:59+00:00"
generated_at: "2026-06-03T21:59:43.747106+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Nektar Therapeutics regains Nasdaq minimum bid price compliance

## Summary
- Received Nasdaq notice on April 17, 2024, confirming compliance regained as of April 16, 2024.
- Common stock closing bid price met $1.00 minimum for 10 consecutive business days.
- Stock had been non-compliant since May 2023 and transferred to Nasdaq Capital Market in November 2023.
- Additional 180-day extension had been granted until May 20, 2024.
- Continued listing on Nasdaq Capital Market is now secure.

## SEC filing metadata
- accession: 0001213900-24-033856
- form_type: 8-K
- ticker: NKTR
- cik: 0000906709
- company_name: NEKTAR THERAPEUTICS
- filed_at: 2024-04-17T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/906709/000121390024033856/0001213900-24-033856-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/906709/000121390024033856/ea0204090-8k_nektar.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-033856
- JSON: https://secwatch.observer/filing/0001213900-24-033856.json
- Plain text: https://secwatch.observer/filing/0001213900-24-033856.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.